Evidence map›Paper›PMID 37461575›Full record

ArticleResearch square2023

Increasing trend of antibiotic resistance in Shigella in Bangladesh: a plasmid-mediated transfer of mphA macrolide resistance gene.

Asaduzzaman Asad, Israt Jahan, Moriam Akter Munni, Ruma Begum, Morium Akter Mukta, Kazi Saif, Shah Nayeem Faruque, Shoma Hayat, Zhahirul Islam

Open access · greenAbstract readPreprint
PubMed Full text at PMC Publisher
In one paragraph

Article in Research square, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Asaduzzaman AsadInternational Centre for Diarrhoeal Disease Research.
Israt JahanInternational Centre for Diarrhoeal Disease Research.
Moriam Akter MunniInternational Centre for Diarrhoeal Disease Research.
Ruma BegumInternational Centre for Diarrhoeal Disease Research.
Morium Akter MuktaInternational Centre for Diarrhoeal Disease Research.
Kazi SaifInternational Centre for Diarrhoeal Disease Research.
Shah Nayeem FaruqueInternational Centre for Diarrhoeal Disease Research.
Shoma HayatInternational Centre for Diarrhoeal Disease Research.
Zhahirul IslamInternational Centre for Diarrhoeal Disease Research.
International Centre for Diarrhoeal Disease Research · BD

Funding

Research Mentoring and Building Capacity of underrepresented Minority Research Scientists in India.D43TW010540 · FIC · YALE UNIVERSITY · PI MICHELE BARRY, Eva Harris · 2017 to 2026
$15.5M
Defining Campylobacter and immune response related determinants in the pathogenesis of Guillain-Barré syndrome patients in low-income countriesK43TW011447 · FIC · INTERNATIONAL CTR/DIARRHOEAL DIS RES · PI ISLAM, ZHAHIRUL · 2019 to 2023
$472k
FIC NIH HHS D43 TW010540FIC NIH HHS K43 TW011447
6 · The paper itself

Abstract

Shigellosis remains a common gastrointestinal disease mostly in children <5 years of age in developing countries. Azithromycin (AZM), a macrolide, is currently the first-line treatment for shigellosis in Bangladesh; ciprofloxacin (CIP) and ceftriaxone (CRO) are also used frequently. We aimed to evaluate the current epidemiology of antimicrobial resistance (AMR) and mechanism(s) of increasing macrolide resistance in

Identifiers

PMID37461575
PMCPMC10350201
OpenAlexW4382517742

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.